Abstract
The organic cation transporter 1, encoded by the SLC22A1 gene, is responsible for the uptake of the anti-hyperglycaemic drug, metformin, in the hepatocyte. We assessed whether a genetic variation in the SLC22A1 gene is associated with the glucose-lowering effect of metformin. Incident metformin users in the Rotterdam Study, whose HbA1c measurements were available, were identified. Associations between 11 tagging single nucleotide polymorphisms in the SLC22A1 gene and change in the HbA1c level were analyzed. A total of 102 incident metformin users were included in this study sample. Except for the rs622342 A>C polymorphism, no significant differences in metformin response were observed. For each minor C allele at rs622342, the reduction in HbA1c levels was 0.28% less (95% CI 0.09–0.47, P=0.005). After Bonferroni correction, the P-value was 0.050. To conclude, genetic variation at rs622342 in the SLC22A1 gene was associated with the glucose-lowering effect of metformin in patients with diabetes mellitus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kirpichnikov D, McFarlane SI, Sowers JR . Metformin: an update. Ann Intern Med 2002; 137: 25–33.
Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000; 49: 2063–2069.
Borst SE, Snellen HG . Metformin, but not exercise training, increases insulin responsiveness in skeletal muscle of Sprague–Dawley rats. Life Sci 2001; 69: 1497–1507.
Takane H, Shikata E, Otsubo K, Higuchi S, Ieiri I . Polymorphism in human organic cation transporters and metformin action. Pharmacogenomics 2008; 9: 415–422.
Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 2007; 117: 1422–1431.
Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y . Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 2002; 302: 510–515.
Wang DS, Kusuhara H, Kato Y, Jonker JW, Schinkel AH, Sugiyama Y . Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol 2003; 63: 844–848.
The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789–796.
Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 2003; 100: 5902–5907.
Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP et al. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 2008; 83: 273–280.
Shikata E, Yamamoto R, Takane H, Shigemasa C, Ikeda T, Otsubo K et al. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. J Hum Genet 2007; 52: 117–122.
Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol 2007; 22: 819–829.
Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA . Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403–422.
Complete ATC index 2008. WHO Collaborating Centre for Drug Statistics Methodology. Web site. Available from: URL: http://www.whocc.no/atcddd/indexdatabase/ Accessed June 20, 2008.
American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008; 31 (Suppl 1): S12–54.
Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008; 371: 1505–1512.
Sentrix HumanHap550 Genotyping Beadchip. Illumina Inc. Web site. Available from: URL: http://www.illumina.com/downloads/HUMANHAP550_DataSheet.pdf. Accessed June 20, 2008.
Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA . Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106–120.
Acknowledgements
We thank Drs JJ Lous for making the STAR–MDC data available for our study and F Rivadeneira, PP Arp and M Jhamai for help with providing the genotyping data.
This study was supported by The Netherlands Organisation for Scientific Research (NWO) (175.01.2005.011) and by The Netherlands Genomics Initiative (NGI) (050-060-810).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Becker, M., Visser, L., van Schaik, R. et al. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J 9, 242–247 (2009). https://doi.org/10.1038/tpj.2009.15
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2009.15
Keywords
This article is cited by
-
Genetic preservation of SLC22A3 in the Admixed and Xhosa populations living in the Western Cape
Molecular Biology Reports (2023)
-
Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
BMC Endocrine Disorders (2022)
-
Analysis of missense SNPs in the SLC47A1 and SLC47A2 genes affecting the pharmacokinetics of metformin: Computational approach
Egyptian Journal of Medical Human Genetics (2022)
-
Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes
Diabetologia (2020)
-
Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
Systematic Reviews (2018)